Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Facilities Realignment (Tables)

Facilities Realignment (Tables)

9 Months Ended

Sep. 30, 2012

Schedule of Restructuring Reserve by Type of Cost [Table Text Block]

The following table presents a rollforward of the Company’s restructuring reserve from December 31, 2011 to September 30, 2012, of which approximately $1.4 million is included in other accrued expenses and $1.7 million is included in long-term liabilities as of September 30, 2012. The Company recognizes accretion expense in Other expense, net in the Condensed Consolidated Statement of Operations.



	Sales Services			Marketing Services			Total
Balance as of December 31, 2011	$	3,417		$	1,072		$	4,489
Accretion	84			22			106
Adjustments	—			(68		)	(68		)
Payments	(1,126		)	(345		)	(1,471		)
Balance as of September 30, 2012	$	2,375		$	681		$	3,056

- Definition

Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.

+ References + Details